Stock THAR THARIMMUNE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Tharimmune, Inc.

Equities

THAR

US4327052001

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-21 pm EDT 		5-day change 1st Jan Change
0.3905 USD +3.86% Intraday chart for Tharimmune, Inc. +7.10% -23.28%
May. 09 Tharimmune, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 23 Tharimmune, Inc. Announces Option Agreement for Key Technologies for Generating HER2/HER3 Antibody Drug Conjugates CI

Turnover - Change in analysts' estimates

EBIT - Change in analysts' estimates

Turnover

EBIT

  1. Stock Market
  2. Equities
  3. THAR Stock
  4. Revisions Tharimmune, Inc.
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW